Revisión bibliográfica: Parches transdérmicos de microagujas para la administración de fármacos anticonceptivos
El uso de métodos anticonceptivos ha presentado problemas de adherencia y aceptabilidad en Colombia y el mundo. Distintos estudios de la OMS indican que las mujeres aún cuando desean evitar el embarazo dejan de usar estos métodos debido a los efectos secundarios que presentan. La industria fármacéut...
- Autores:
-
Reina López, Laura Camila
Rodríguez Tavera, Ricardo Andrés
- Tipo de recurso:
- https://purl.org/coar/resource_type/c_7a1f
- Fecha de publicación:
- 2024
- Institución:
- Universidad El Bosque
- Repositorio:
- Repositorio U. El Bosque
- Idioma:
- spa
- OAI Identifier:
- oai:repositorio.unbosque.edu.co:20.500.12495/14370
- Acceso en línea:
- https://hdl.handle.net/20.500.12495/14370
- Palabra clave:
- Parches transdérmicos de microagujas
Liberación controlada
Microagujas biodegradables
Levonorgestrel
Aceptabilidad
Adherencia
615.19
Transdermal microneedle patches
Controlled release
Biodegradable microneedles
Levonorgestrel
Acceptability
Adherence
- Rights
- License
- Attribution-NonCommercial-NoDerivatives 4.0 International
id |
UNBOSQUE2_a2ed1cd856af053b916de5b06bccaf8b |
---|---|
oai_identifier_str |
oai:repositorio.unbosque.edu.co:20.500.12495/14370 |
network_acronym_str |
UNBOSQUE2 |
network_name_str |
Repositorio U. El Bosque |
repository_id_str |
|
dc.title.none.fl_str_mv |
Revisión bibliográfica: Parches transdérmicos de microagujas para la administración de fármacos anticonceptivos |
dc.title.translated.none.fl_str_mv |
Literature review: Transdermal microneedle patches transdermal microneedle patches for contraceptive drug delivery |
title |
Revisión bibliográfica: Parches transdérmicos de microagujas para la administración de fármacos anticonceptivos |
spellingShingle |
Revisión bibliográfica: Parches transdérmicos de microagujas para la administración de fármacos anticonceptivos Parches transdérmicos de microagujas Liberación controlada Microagujas biodegradables Levonorgestrel Aceptabilidad Adherencia 615.19 Transdermal microneedle patches Controlled release Biodegradable microneedles Levonorgestrel Acceptability Adherence |
title_short |
Revisión bibliográfica: Parches transdérmicos de microagujas para la administración de fármacos anticonceptivos |
title_full |
Revisión bibliográfica: Parches transdérmicos de microagujas para la administración de fármacos anticonceptivos |
title_fullStr |
Revisión bibliográfica: Parches transdérmicos de microagujas para la administración de fármacos anticonceptivos |
title_full_unstemmed |
Revisión bibliográfica: Parches transdérmicos de microagujas para la administración de fármacos anticonceptivos |
title_sort |
Revisión bibliográfica: Parches transdérmicos de microagujas para la administración de fármacos anticonceptivos |
dc.creator.fl_str_mv |
Reina López, Laura Camila Rodríguez Tavera, Ricardo Andrés |
dc.contributor.advisor.none.fl_str_mv |
Velandia Paris, María Angélica |
dc.contributor.author.none.fl_str_mv |
Reina López, Laura Camila Rodríguez Tavera, Ricardo Andrés |
dc.subject.none.fl_str_mv |
Parches transdérmicos de microagujas Liberación controlada Microagujas biodegradables Levonorgestrel Aceptabilidad Adherencia |
topic |
Parches transdérmicos de microagujas Liberación controlada Microagujas biodegradables Levonorgestrel Aceptabilidad Adherencia 615.19 Transdermal microneedle patches Controlled release Biodegradable microneedles Levonorgestrel Acceptability Adherence |
dc.subject.ddc.none.fl_str_mv |
615.19 |
dc.subject.keywords.none.fl_str_mv |
Transdermal microneedle patches Controlled release Biodegradable microneedles Levonorgestrel Acceptability Adherence |
description |
El uso de métodos anticonceptivos ha presentado problemas de adherencia y aceptabilidad en Colombia y el mundo. Distintos estudios de la OMS indican que las mujeres aún cuando desean evitar el embarazo dejan de usar estos métodos debido a los efectos secundarios que presentan. La industria fármacéutica ha explorado diversos métodos anticonceptivos, en donde se han incluido los parches transdérmicos de microagujas como una alternativa con menos efectos secundarios y mayor adherencia al tratamiento. Se realizó una revisión bibliográfica utilizando la metodología PRISMA, donde se emplearon criterios de inclusión y exclusión, allí se analizaron 50 artículos con el fin de dar cumplimiento a los objetivos planteados. Se determinó que los parches transdérmicos de microagujas ofrecen ventajas significativas como una liberación controlada de fármacos. Los diferentes tipos de microagujas (sólidas, recubiertas, biodegradables, huecas y de hidrogel), demostraron diferencias en eficacia y caracteristicas de liberación. Las microagujas biodegradables permiten una liberación controlada de Levonorgestrel de hasta 45 días sin dejar ningún residuo biopeligroso, lo que convierte a los parches transdérmicos de microagujas en una opción innovadora y viable para la administración de Levonorgestrel debido a que facilita la entrega, siendo más eficiente y controlada, permitiendo mayor adherencia y aceptabilidad por los pacientes. |
publishDate |
2024 |
dc.date.issued.none.fl_str_mv |
2024-10 |
dc.date.accessioned.none.fl_str_mv |
2025-05-16T16:33:48Z |
dc.date.available.none.fl_str_mv |
2025-05-16T16:33:48Z |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_7a1f |
dc.type.local.none.fl_str_mv |
Tesis/Trabajo de grado - Monografía - Pregrado |
dc.type.coar.none.fl_str_mv |
https://purl.org/coar/resource_type/c_7a1f |
dc.type.driver.none.fl_str_mv |
info:eu-repo/semantics/bachelorThesis |
dc.type.coarversion.none.fl_str_mv |
https://purl.org/coar/version/c_ab4af688f83e57aa |
format |
https://purl.org/coar/resource_type/c_7a1f |
dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/20.500.12495/14370 |
dc.identifier.instname.spa.fl_str_mv |
Universidad El Bosque |
dc.identifier.reponame.spa.fl_str_mv |
reponame:Repositorio Institucional Universidad El Bosque |
dc.identifier.repourl.none.fl_str_mv |
repourl:https://repositorio.unbosque.edu.co |
url |
https://hdl.handle.net/20.500.12495/14370 |
identifier_str_mv |
Universidad El Bosque reponame:Repositorio Institucional Universidad El Bosque repourl:https://repositorio.unbosque.edu.co |
dc.language.iso.fl_str_mv |
spa |
language |
spa |
dc.relation.references.none.fl_str_mv |
1. Bitzer, J. La Realidad de Los Métodos Anticonceptivos. SciELO 2018, 23. 2. Organización Mundial de la Salud Un Nuevo Estudio de La OMS Relaciona Las Altas Tasas de Embarazos No Planificados Con Las Deficiencias de Los Servicios de Planificación Familiar Available online: https://www.who.int/es/news/item/25-10-2019-high-rates-of-unintended-pregnancies-linked-to-gaps-in-family-planning-services-new-who-study. 3. Gordon, L.P. El Método Ogino (o de Abstinencia Periódica Basada En El Ciclo Menstrual) Available online: https://kidshealth.org/es/teens/contraception-rhythm.html#:~:text=El%20m%C3%A9todo%20Ogino%20es%20una,ciclo%20mensual%20de%20una%20mujer. 4. Cuervo-Vergara, S.A.; Garrido-Gutiérrez, J.D.; Vélez-Álvarez, G.A.; Zuleta-Tobón, J.J. Asociación Entre Conocimientos de Anticoncepción y Embarazo No Planeado. Estudio de Corte Transversal. Rev Colomb Obstet Ginecol 2015, 66, 160, doi:10.18597/rcog.21. 5. Organización Mundial de la Salud Organización Mundial de La Salud Departamento de Salud Reproductiva e Investigaciones Conexas. 6. MinSalud; Profamilia Encuesta Nacional de Demografía y Salud; 2015; 7. MinSalud; Profamilia Conocimiento y Uso de Los Métodos Anticonceptivos Entre Los Colombianos Available online: https://www.minsalud.gov.co/Documents/General/20161212_B_ENDS%202015_Metodos_anticonceptivos.pdf. 8. Park, P. Park’s Textbook of Preventive and Social Medicine; 24th ed.; Banarsidas Bhanot Publishers, 2017; 9. National Institutes of Health ¿Cuáles Son Los Diferentes Tipos de Anticonceptivos? Available online: https://espanol.nichd.nih.gov/salud/temas/contraception/informacion/tipos. 10. AEMPS Parches Transdérmicos 11. Goldsmith, A.; Edelman, D.A. Tecnología Anticonceptiva: Presente y Futuro. Rev Colomb Obstet Ginecol 2021, 30, 93–101, doi:10.18597/rcog.2253. 12. Chen, X.; Z.Y.-P.X.J.S.X.-L.L.Y.G.L.W.Z.-H. [Preparation of Triptolide-Loaded Dissolving Microneedles and Its Transdermal Penetration]. Pubmed 2021, 46, 5278–5283, doi:10.19540/j.cnki.cjcmm.20210330.303. 13. McCrudden, M.T.C.; McAlister, E.; Courtenay, A.J.; González‐Vázquez, P.; Raj Singh, T.R.; Donnelly, R.F. Microneedle Applications in Improving Skin Appearance. Exp Dermatol 2015, 24, 561–566, doi:10.1111/exd.12723. 14. Gómez Sánchez, P.I. ANTICONCEPCIÓN: PASADO, PRESENTE Y FUTURO; 1st ed.; Editorial Universidad Nacional de Colombia, 2010; 15. Bitzer, J.; Gemzell-Danielsson, K.; Roumen, F.; Marintcheva-Petrova, M.; van Bakel, B.; Oddens, B.J. The CHOICE Study: Effect of Counselling on the Selection of Combined Hormonal Contraceptive Methods in 11 Countries. The European Journal of Contraception & Reproductive Health Care 2012, 17, 65–78, doi:10.3109/13625187.2011.637586. 16. Karve, T.; Dandekar, A.; Agrahari, V.; Melissa Peet, M.; Banga, A.K.; Doncel, G.F. Long-Acting Transdermal Drug Delivery Formulations: Current Developments and Innovative Pharmaceutical Approaches. Adv Drug Deliv Rev 2024, 210, doi:10.1016/j.addr.2024.115326. 17. Gupta, D.R.; Prabhakar, B.; Wairkar, S. Non-Oral Routes, Novel Formulations and Devices of Contraceptives: An Update. Journal of Controlled Release 2022, 345, 798–810, doi:10.1016/j.jconrel.2022.03.057. 18. Rojas Mena, A.A. AVANCES EN TECNOLOGÍA: PARCHES DE MICROAGUJAS. Trabajo Fin de Grado, UNIVERSIDAD COMPLUTENSE, 2017. 19. María Pilar Nakhle Eid Avances En Los Sistemas Transdermicos Para La Administracion de Farmacos (4), Universidad de la Laguna, 2022. 20. Baryakova, T.H.; Pogostin, B.H.; Langer, R.; McHugh, K.J. Overcoming Barriers to Patient Adherence: The Case for Developing Innovative Drug Delivery Systems. Nat Rev Drug Discov 2023, 22, 387–409, doi:10.1038/s41573-023-00670-0. 21. Lee, D.H.; Lim, S.; Kwak, S.S.; Kim, J. Advancements in Skin-Mediated Drug Delivery: Mechanisms, Techniques, and Applications. Adv Healthc Mater 2024, 13, doi:10.1002/adhm.202302375. 22. Berdai Jiménez, S. El Administración Transdérmica de Fármacos En Microagujas. Trabajo fin de Grado, UNIVERSIDAD COMPLUTENSE, 2020. 23. Le, Z.; Yu, J.; Quek, Y.J.; Bai, B.; Li, X.; Shou, Y.; Myint, B.; Xu, C.; Tay, A. Design Principles of Microneedles for Drug Delivery and Sampling Applications. Materials Today 2023, 63, 137–169, doi:10.1016/j.mattod.2022.10.025. 24. Jung, J.H.; Jin, S.G. Microneedle for Transdermal Drug Delivery: Current Trends and Fabrication. J Pharm Investig 2021, 51, 503–517, doi:10.1007/s40005-021-00512-4. 25. Wong, W.F.; Ang, K.P.; Sethi, G.; Looi, C.Y. Recent Advancement of Medical Patch for Transdermal Drug Delivery. Medicina (Lithuania) 2023, 59, doi:10.3390/medicina59040778. 26. Yao, G.; Quan, G.; Lin, S.; Peng, T.; Wang, Q.; Ran, H.; Chen, H.; Zhang, Q.; Wang, L.; Pan, X.; et al. Novel Dissolving Microneedles for Enhanced Transdermal Delivery of Levonorgestrel: In Vitro and in Vivo Characterization. Int J Pharm 2017, 534, 378–386, doi:10.1016/j.ijpharm.2017.10.035. 27. Altuntaş, E.; Tekko, I.A.; Vora, L.K.; Kumar, N.; Brodsky, R.; Chevallier, O.; McAlister, E.; Kurnia Anjani, Q.; McCarthy, H.O.; Donnelly, R.F. Nestorone Nanosuspension-Loaded Dissolving Microneedles Array Patch: A Promising Novel Approach for “on-Demand” Hormonal Female-Controlled Peritcoital Contraception. Int J Pharm 2022, 614, doi:10.1016/j.ijpharm.2021.121422. 28. Jiang, X.; Zeng, Y.; Zhang, W.; Wang, C.; Li, W. Advances in Microneedle Patches for Long-Acting Contraception. Acta Materia Medica 2023, 2, doi:10.15212/AMM-2022-0042. 29. Li, W.; Terry, R.N.; Tang, J.; Feng, M.R.; Schwendeman, S.P.; Prausnitz, M.R. Rapidly Separable Microneedle Patch for the Sustained Release of a Contraceptive. Nat Biomed Eng 2019, 3, 220–229, doi:10.1038/s41551-018-0337-4. 30. Abdelkader, H.; Fathalla, Z.; Seyfoddin, A.; Farahani, M.; Thrimawithana, T.; Allahham, A.; Alani, A.W.G.; Al-Kinani, A.A.; Alany, R.G. Polymeric Long-Acting Drug Delivery Systems (LADDS) for Treatment of Chronic Diseases: Inserts, Patches, Wafers, and Implants. Adv Drug Deliv Rev 2021, 177, doi:10.1016/j.addr.2021.113957. 31. Zhang, W.; Zhang, W.; Li, C.; Zhang, J.; Qin, L.; Lai, Y. Recent Advances of Microneedles and Their Application in Disease Treatment. Int J Mol Sci 2022, 23, doi:10.3390/ijms23052401. 32. Yadav, P.R.; Munni, M.N.; Campbell, L.; Mostofa, G.; Dobson, L.; Shittu, M.; Pattanayek, S.K.; Uddin, M.J.; Bhusan Das, D. Translation of Polymeric Microneedles for Treatment of Human Diseases: Recent Trends, Progress, and Challenges. Pharmaceutics 2021, 13, doi:10.3390/pharmaceutics13081132. 33. Avcil, M.; Çelik, A. Microneedles in Drug Delivery: Progress and Challenges. Micromachines (Basel) 2021, 12, doi:10.3390/mi12111321. 34. Priya, B.; Manoj, K.; Navneet, K. A Review of Recent Advancement of Transdermal Drug Delivery Systems. International Journal of Research Development and Technology 2023, 1. 35. Sheth, N.S.; Mistry, R.B. Formulation and Evaluation of Transdermal Patches and to Study Permeation Enhancement Effect of Eugenol. J Appl Pharm Sci 2011, 01, 96–101. 36. Kim, S.; Kim, J.H.; Jeon, O.; Kwon, I.C.; Park, K. Engineered Polymers for Advanced Drug Delivery. European Journal of Pharmaceutics and Biopharmaceutics 2009, 71, 420–430, doi:10.1016/j.ejpb.2008.09.021. 37. Vora, L.K.; Sabri, A.H.; Naser, Y.; Himawan, A.; Hutton, A.R.J.; Anjani, Q.K.; Volpe-Zanutto, F.; Mishra, D.; Li, M.; Rodgers, A.M.; et al. Long-Acting Microneedle Formulations. Adv Drug Deliv Rev 2023, 201, doi:10.1016/j.addr.2023.115055. 38. Parhi, R. Recent Advances in Microneedle Designs and Their Applications in Drug and Cosmeceutical Delivery. J Drug Deliv Sci Technol 2022, 75, doi:10.1016/j.jddst.2022.103639. 39. Filho, D.; Guerrero, M.; Pariguana, M.; Marican, A.; Durán-Lara, E.F. Hydrogel-Based Microneedle as a Drug Delivery System. Pharmaceutics 2023, 15, doi:10.3390/pharmaceutics15102444. 40. Hou, X.; Li, J.; Hong, Y.; Ruan, H.; Long, M.; Feng, N.; Zhang, Y. Advances and Prospects for Hydrogel-Forming Microneedles in Transdermal Drug Delivery. Biomedicines 2023, 11, doi:10.3390/biomedicines11082119. 41. Luo, X.; Yang, L.; Cui, Y. Microneedles: Materials, Fabrication, and Biomedical Applications. Biomed Microdevices 2023, 25, doi:10.1007/s10544-023-00658-y. 42. Parhi, R.; Divya Supriya, N. Review of Microneedle Based Transdermal Drug Delivery Systems. International Journal of Pharmaceutical Sciences and Nanotechnology 2019, 12, doi:10.37285/ijpsn.2019.12.3.1. 43. Halder, J.; Gupta, S.; Kumari, R.; Gupta, G. Das; Rai, V.K. Microneedle Array: Applications, Recent Advances, and Clinical Pertinence in Transdermal Drug Delivery. J Pharm Innov 2021, 16, 558–565, doi:10.1007/s12247-020-09460-2. 44. Rathor, S.; Ram, A.; Ghasidas Vishwavidyalaya, G. ADVANCEMENT IN TRANSDERMAL DRUG DELIVERY SYSTEM : MICRONEEDLES. Asian Journal of Pharmaceutical Research and Development 2017, 5, 1–07. 45. Oliveira, C.; Teixeira, J.A.; Oliveira, N.; Ferreira, S.; Botelho, C.M. Microneedles’ Device: Design, Fabrication, and Applications. Macromol 2024, 4, 320–355, doi:10.3390/macromol4020019. 46. Vora, L.K.; Moffatt, K.; Tekko, I.A.; Paredes, A.J.; Volpe-Zanutto, F.; Mishra, D.; Peng, K.; Raj Singh Thakur, R.; Donnelly, R.F. Microneedle Array Systems for Long-Acting Drug Delivery. European Journal of Pharmaceutics and Biopharmaceutics 2021, 159, 44–76, doi:10.1016/j.ejpb.2020.12.006. 47. Singh, P.; Carrier, A.; Chen, Y.; Lin, S.; Wang, J.; Cui, S.; Zhang, X. Polymeric Microneedles for Controlled Transdermal Drug Delivery. Journal of Controlled Release 2019, 315, 97–113, doi:10.1016/j.jconrel.2019.10.022. 48. Wang, S.; Zhao, M.; Yan, Y.; Li, P.; Huang, W. Flexible Monitoring, Diagnosis, and Therapy by Microneedles with Versatile Materials and Devices toward Multifunction Scope. Research 2023, 6, 01–28, doi:10.34133/research.0128. 49. Loh, J.M.; Lim, Y.J.L.; Tay, J.T.; Cheng, H.M.; Tey, H.L.; Liang, K. Design and Fabrication of Customizable Microneedles Enabled by 3D Printing for Biomedical Applications. Bioact Mater 2024, 32, 222–241, doi:10.1016/j.bioactmat.2023.09.022. 50. Serrano Castañeda, P. Desarrollo de Una Nueva Forma Farmacéutica a Base de Microagujas Poliméricas Biodegradables Acopladas a Un Parche Transdérmico Para La Liberación de Fármacos. Tesis, UNIVERSIDAD AUTÓNOMA METROPOLITANA, 2019. 51. Magill, E.; Demartis, S.; Gavini, E.; Permana, A.D.; Thakur, R.R.S.; Adrianto, M.F.; Waite, D.; Glover, K.; Picco, C.J.; Korelidou, A.; et al. Solid Implantable Devices for Sustained Drug Delivery. Adv Drug Deliv Rev 2023, 199, doi:10.1016/j.addr.2023.114950. 52. Conrad, R. ¿Qué Es Moldeo Por Inyección? Available online: https://www.elastomer.kuraray.com/es/blog/injection-molding/ (accessed on 21 September 2024). 53. Xu, J.; Xu, D.; Xuan, X.; He, H. Advances of Microneedles in Biomedical Applications. Molecules 2021, 26, doi:10.3390/molecules26195912. 54. Ramadon, D.; McCrudden, M.T.C.; Courtenay, A.J.; Donnelly, R.F. Enhancement Strategies for Transdermal Drug Delivery Systems: Current Trends and Applications. Drug Deliv Transl Res 2022, 12, 758–791, doi:10.1007/s13346-021-00909-6. 55. Sabri, A.H.; Kim, Y.; Marlow, M.; Scurr, D.J.; Segal, J.; Banga, A.K.; Kagan, L.; Lee, J.B. Intradermal and Transdermal Drug Delivery Using Microneedles – Fabrication, Performance Evaluation and Application to Lymphatic Delivery. Adv Drug Deliv Rev 2020, 153, 195–215, doi:10.1016/j.addr.2019.10.004. 56. Morales Florido, M.I.; Miranda Calderón, J.E.; Gómez Sámano, M.A.; Escobar Chávez, J.J. Microneedles as an Alternative Strategy for Drug Delivery. J Pharm Pharm Sci 2022, 25, 93–109. 57. Ebrahiminejad, V.; Rad, Z.F.; Prewett, P.D.; Davies, G.J. Fabrication and Testing of Polymer Microneedles for Transdermal Drug Delivery. Beilstein Journal of Nanotechnologyp0o 2022, 13, 629–640, doi:10.3762/bjnano.13.55. 58. Li, W.; Tang, J.; Terry, R.N.; Li, S.; Brunie, A.; Callahan, R.L.; Noel, R.K.; Rodríguez, C.A.; Schwendeman, S.P.; Prausnitz, M.R. Long-Acting Reversible Contraception by Effervescent Microneedle Patch. Sci Adv 2019, 5. 59. Li, W.; Chen, J.Y.; Terry, R.N.; Tang, J.; Romanyuk, A.; Schwendeman, S.P.; Prausnitz, M.R. Core-Shell Microneedle Patch for Six-Month Controlled-Release Contraceptive Delivery. Journal of Controlled Release 2022, 347, 489–499, doi:10.1016/j.jconrel.2022.04.051. 60. Paredes, A.J.; Ramöller, I.K.; McKenna, P.E.; Abbate, M.T.A.; Volpe-Zanutto, F.; Vora, L.K.; Kilbourne-Brook, M.; Jarrahian, C.; Moffatt, K.; Zhang, C.; et al. Microarray Patches: Breaking down the Barriers to Contraceptive Care and HIV Prevention for Women across the Globe. Adv Drug Deliv Rev 2021, 173, 331–348, doi:10.1016/j.addr.2021.04.002. 61. Xu, C.; Wu, Y.; Zhao, L.; Zhou, W.; Li, Y.; Yi, X.; Wang, Y.; Zhang, Q.; Hu, H.; Wang, Z. Transdermal Hormone Delivery: Strategies, Application and Modality Selection. J Drug Deliv Sci Technol 2023, 86, doi:10.1016/j.jddst.2023.104730. 62. Yavuz, B.; Chambre, L.; Harrington, K.; Kluge, J.; Valenti, L.; Kaplan, D.L. Silk Fibroin Microneedle Patches for the Sustained Release of Levonorgestrel. ACS Appl Bio Mater 2020, 3, 5375–5382, doi:10.1021/acsabm.0c00671. 63. Sivasankaran, S.; Jonnalagadda, S. Advances in Controlled Release Hormonal Technologies for Contraception: A Review of Existing Devices, Underlying Mechanisms, and Future Directions. Journal of Controlled Release 2021, 330, 797–811, doi:10.1016/j.jconrel.2020.12.044. 64. VADEMECUM ORTHO EVRA Transdermal Patch 150 Μg/24 H+20 Μg/24 h Available online: https://www.vademecum.es/estados-unidos/medicamento/28003194/ortho-evra-transdermal-patch-150-g-24-h-20-g-24-h (accessed on 18 September 2024). 65. Li, W.; Li, S.; Fan, X.; Prausnitz, M.R. Microneedle Patch Designs to Increase Dose Administered to Human Subjects. Journal of Controlled Release 2021, 339, 350–360, doi:10.1016/j.jconrel.2021.09.036. |
dc.rights.en.fl_str_mv |
Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.uri.none.fl_str_mv |
http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.rights.local.spa.fl_str_mv |
Acceso abierto |
dc.rights.accessrights.none.fl_str_mv |
https://purl.org/coar/access_right/c_abf2 |
rights_invalid_str_mv |
Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ Acceso abierto https://purl.org/coar/access_right/c_abf2 http://purl.org/coar/access_right/c_abf2 |
dc.format.mimetype.none.fl_str_mv |
application/pdf |
dc.publisher.program.spa.fl_str_mv |
Química Farmacéutica |
dc.publisher.grantor.spa.fl_str_mv |
Universidad El Bosque |
dc.publisher.faculty.spa.fl_str_mv |
Facultad de Ciencias |
institution |
Universidad El Bosque |
bitstream.url.fl_str_mv |
https://repositorio.unbosque.edu.co/bitstreams/5994f216-e4bc-428f-bea3-f47c42129827/download https://repositorio.unbosque.edu.co/bitstreams/3488d174-4a7d-428e-94c3-fe89932ca878/download https://repositorio.unbosque.edu.co/bitstreams/a241cdf4-5e83-47b1-ad2f-e1999bd26600/download https://repositorio.unbosque.edu.co/bitstreams/0f8bb21c-3805-4860-9bb5-e35230e2074b/download https://repositorio.unbosque.edu.co/bitstreams/f84163eb-1a24-458d-acb8-e425a0d62466/download https://repositorio.unbosque.edu.co/bitstreams/103b6d3e-78df-4632-bbdb-4823d64b2ada/download https://repositorio.unbosque.edu.co/bitstreams/faca2af6-f3df-4d3e-9ec8-3eae7037f962/download |
bitstream.checksum.fl_str_mv |
2d4dbde23a1b09abc868db9e6319b1d0 17cc15b951e7cc6b3728a574117320f9 50d1fad5d04646c0db64ba23911f52ca cd98236ce1b2437c9789dccf356155b2 3b6ce8e9e36c89875e8cf39962fe8920 96fb12b18d34d4d228dda83669147eca 781886de6d18912222dccf6df3e0a2d9 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio Institucional Universidad El Bosque |
repository.mail.fl_str_mv |
bibliotecas@biteca.com |
_version_ |
1834107964253798400 |
spelling |
Velandia Paris, María AngélicaReina López, Laura CamilaRodríguez Tavera, Ricardo Andrés2025-05-16T16:33:48Z2025-05-16T16:33:48Z2024-10https://hdl.handle.net/20.500.12495/14370Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquerepourl:https://repositorio.unbosque.edu.coEl uso de métodos anticonceptivos ha presentado problemas de adherencia y aceptabilidad en Colombia y el mundo. Distintos estudios de la OMS indican que las mujeres aún cuando desean evitar el embarazo dejan de usar estos métodos debido a los efectos secundarios que presentan. La industria fármacéutica ha explorado diversos métodos anticonceptivos, en donde se han incluido los parches transdérmicos de microagujas como una alternativa con menos efectos secundarios y mayor adherencia al tratamiento. Se realizó una revisión bibliográfica utilizando la metodología PRISMA, donde se emplearon criterios de inclusión y exclusión, allí se analizaron 50 artículos con el fin de dar cumplimiento a los objetivos planteados. Se determinó que los parches transdérmicos de microagujas ofrecen ventajas significativas como una liberación controlada de fármacos. Los diferentes tipos de microagujas (sólidas, recubiertas, biodegradables, huecas y de hidrogel), demostraron diferencias en eficacia y caracteristicas de liberación. Las microagujas biodegradables permiten una liberación controlada de Levonorgestrel de hasta 45 días sin dejar ningún residuo biopeligroso, lo que convierte a los parches transdérmicos de microagujas en una opción innovadora y viable para la administración de Levonorgestrel debido a que facilita la entrega, siendo más eficiente y controlada, permitiendo mayor adherencia y aceptabilidad por los pacientes.PregradoQuímico FarmacéuticoThe use of contraceptive methods has presented problems of adherence and acceptability in Colombia and the world. Different WHO studies indicate that even when women want to avoid pregnancy, they stop using these methods due to the side effects they present. The pharmaceutical industry has explored various contraceptive methods, where transdermal microneedle patches have been included as an alternative with fewer side effects and greater adherence to treatment. A bibliographic review was carried out using the PRISMA methodology, where inclusion and exclusion criteria were used, and 50 articles were analyzed in order to fulfill the objectives. It was determined that transdermal microneedle patches offer significant advantages such as controlled drug release. The different types of microneedles (solid, coated, biodegradable, hollow and hydrogel) showed differences in efficacy and release characteristics. Biodegradable microneedles allow a controlled release of Levonorgestrel for up to 45 days without leaving any biohazardous residue, which makes transdermal microneedle patches an innovative and viable option for Levonorgestrel administration because it facilitates delivery, being more efficient and controlled, allowing greater adherence and acceptability by patients.application/pdfAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/Acceso abiertohttps://purl.org/coar/access_right/c_abf2http://purl.org/coar/access_right/c_abf2Parches transdérmicos de microagujasLiberación controladaMicroagujas biodegradablesLevonorgestrelAceptabilidadAdherencia615.19Transdermal microneedle patchesControlled releaseBiodegradable microneedlesLevonorgestrelAcceptabilityAdherenceRevisión bibliográfica: Parches transdérmicos de microagujas para la administración de fármacos anticonceptivosLiterature review: Transdermal microneedle patches transdermal microneedle patches for contraceptive drug deliveryQuímica FarmacéuticaUniversidad El BosqueFacultad de CienciasTesis/Trabajo de grado - Monografía - Pregradohttps://purl.org/coar/resource_type/c_7a1fhttp://purl.org/coar/resource_type/c_7a1finfo:eu-repo/semantics/bachelorThesishttps://purl.org/coar/version/c_ab4af688f83e57aa1. Bitzer, J. La Realidad de Los Métodos Anticonceptivos. SciELO 2018, 23.2. Organización Mundial de la Salud Un Nuevo Estudio de La OMS Relaciona Las Altas Tasas de Embarazos No Planificados Con Las Deficiencias de Los Servicios de Planificación Familiar Available online: https://www.who.int/es/news/item/25-10-2019-high-rates-of-unintended-pregnancies-linked-to-gaps-in-family-planning-services-new-who-study.3. Gordon, L.P. El Método Ogino (o de Abstinencia Periódica Basada En El Ciclo Menstrual) Available online: https://kidshealth.org/es/teens/contraception-rhythm.html#:~:text=El%20m%C3%A9todo%20Ogino%20es%20una,ciclo%20mensual%20de%20una%20mujer.4. Cuervo-Vergara, S.A.; Garrido-Gutiérrez, J.D.; Vélez-Álvarez, G.A.; Zuleta-Tobón, J.J. Asociación Entre Conocimientos de Anticoncepción y Embarazo No Planeado. Estudio de Corte Transversal. Rev Colomb Obstet Ginecol 2015, 66, 160, doi:10.18597/rcog.21.5. Organización Mundial de la Salud Organización Mundial de La Salud Departamento de Salud Reproductiva e Investigaciones Conexas.6. MinSalud; Profamilia Encuesta Nacional de Demografía y Salud; 2015;7. MinSalud; Profamilia Conocimiento y Uso de Los Métodos Anticonceptivos Entre Los Colombianos Available online: https://www.minsalud.gov.co/Documents/General/20161212_B_ENDS%202015_Metodos_anticonceptivos.pdf.8. Park, P. Park’s Textbook of Preventive and Social Medicine; 24th ed.; Banarsidas Bhanot Publishers, 2017;9. National Institutes of Health ¿Cuáles Son Los Diferentes Tipos de Anticonceptivos? Available online: https://espanol.nichd.nih.gov/salud/temas/contraception/informacion/tipos.10. AEMPS Parches Transdérmicos11. Goldsmith, A.; Edelman, D.A. Tecnología Anticonceptiva: Presente y Futuro. Rev Colomb Obstet Ginecol 2021, 30, 93–101, doi:10.18597/rcog.2253.12. Chen, X.; Z.Y.-P.X.J.S.X.-L.L.Y.G.L.W.Z.-H. [Preparation of Triptolide-Loaded Dissolving Microneedles and Its Transdermal Penetration]. Pubmed 2021, 46, 5278–5283, doi:10.19540/j.cnki.cjcmm.20210330.303.13. McCrudden, M.T.C.; McAlister, E.; Courtenay, A.J.; González‐Vázquez, P.; Raj Singh, T.R.; Donnelly, R.F. Microneedle Applications in Improving Skin Appearance. Exp Dermatol 2015, 24, 561–566, doi:10.1111/exd.12723.14. Gómez Sánchez, P.I. ANTICONCEPCIÓN: PASADO, PRESENTE Y FUTURO; 1st ed.; Editorial Universidad Nacional de Colombia, 2010;15. Bitzer, J.; Gemzell-Danielsson, K.; Roumen, F.; Marintcheva-Petrova, M.; van Bakel, B.; Oddens, B.J. The CHOICE Study: Effect of Counselling on the Selection of Combined Hormonal Contraceptive Methods in 11 Countries. The European Journal of Contraception & Reproductive Health Care 2012, 17, 65–78, doi:10.3109/13625187.2011.637586.16. Karve, T.; Dandekar, A.; Agrahari, V.; Melissa Peet, M.; Banga, A.K.; Doncel, G.F. Long-Acting Transdermal Drug Delivery Formulations: Current Developments and Innovative Pharmaceutical Approaches. Adv Drug Deliv Rev 2024, 210, doi:10.1016/j.addr.2024.115326.17. Gupta, D.R.; Prabhakar, B.; Wairkar, S. Non-Oral Routes, Novel Formulations and Devices of Contraceptives: An Update. Journal of Controlled Release 2022, 345, 798–810, doi:10.1016/j.jconrel.2022.03.057.18. Rojas Mena, A.A. AVANCES EN TECNOLOGÍA: PARCHES DE MICROAGUJAS. Trabajo Fin de Grado, UNIVERSIDAD COMPLUTENSE, 2017.19. María Pilar Nakhle Eid Avances En Los Sistemas Transdermicos Para La Administracion de Farmacos (4), Universidad de la Laguna, 2022.20. Baryakova, T.H.; Pogostin, B.H.; Langer, R.; McHugh, K.J. Overcoming Barriers to Patient Adherence: The Case for Developing Innovative Drug Delivery Systems. Nat Rev Drug Discov 2023, 22, 387–409, doi:10.1038/s41573-023-00670-0.21. Lee, D.H.; Lim, S.; Kwak, S.S.; Kim, J. Advancements in Skin-Mediated Drug Delivery: Mechanisms, Techniques, and Applications. Adv Healthc Mater 2024, 13, doi:10.1002/adhm.202302375.22. Berdai Jiménez, S. El Administración Transdérmica de Fármacos En Microagujas. Trabajo fin de Grado, UNIVERSIDAD COMPLUTENSE, 2020.23. Le, Z.; Yu, J.; Quek, Y.J.; Bai, B.; Li, X.; Shou, Y.; Myint, B.; Xu, C.; Tay, A. Design Principles of Microneedles for Drug Delivery and Sampling Applications. Materials Today 2023, 63, 137–169, doi:10.1016/j.mattod.2022.10.025.24. Jung, J.H.; Jin, S.G. Microneedle for Transdermal Drug Delivery: Current Trends and Fabrication. J Pharm Investig 2021, 51, 503–517, doi:10.1007/s40005-021-00512-4.25. Wong, W.F.; Ang, K.P.; Sethi, G.; Looi, C.Y. Recent Advancement of Medical Patch for Transdermal Drug Delivery. Medicina (Lithuania) 2023, 59, doi:10.3390/medicina59040778.26. Yao, G.; Quan, G.; Lin, S.; Peng, T.; Wang, Q.; Ran, H.; Chen, H.; Zhang, Q.; Wang, L.; Pan, X.; et al. Novel Dissolving Microneedles for Enhanced Transdermal Delivery of Levonorgestrel: In Vitro and in Vivo Characterization. Int J Pharm 2017, 534, 378–386, doi:10.1016/j.ijpharm.2017.10.035.27. Altuntaş, E.; Tekko, I.A.; Vora, L.K.; Kumar, N.; Brodsky, R.; Chevallier, O.; McAlister, E.; Kurnia Anjani, Q.; McCarthy, H.O.; Donnelly, R.F. Nestorone Nanosuspension-Loaded Dissolving Microneedles Array Patch: A Promising Novel Approach for “on-Demand” Hormonal Female-Controlled Peritcoital Contraception. Int J Pharm 2022, 614, doi:10.1016/j.ijpharm.2021.121422.28. Jiang, X.; Zeng, Y.; Zhang, W.; Wang, C.; Li, W. Advances in Microneedle Patches for Long-Acting Contraception. Acta Materia Medica 2023, 2, doi:10.15212/AMM-2022-0042.29. Li, W.; Terry, R.N.; Tang, J.; Feng, M.R.; Schwendeman, S.P.; Prausnitz, M.R. Rapidly Separable Microneedle Patch for the Sustained Release of a Contraceptive. Nat Biomed Eng 2019, 3, 220–229, doi:10.1038/s41551-018-0337-4.30. Abdelkader, H.; Fathalla, Z.; Seyfoddin, A.; Farahani, M.; Thrimawithana, T.; Allahham, A.; Alani, A.W.G.; Al-Kinani, A.A.; Alany, R.G. Polymeric Long-Acting Drug Delivery Systems (LADDS) for Treatment of Chronic Diseases: Inserts, Patches, Wafers, and Implants. Adv Drug Deliv Rev 2021, 177, doi:10.1016/j.addr.2021.113957.31. Zhang, W.; Zhang, W.; Li, C.; Zhang, J.; Qin, L.; Lai, Y. Recent Advances of Microneedles and Their Application in Disease Treatment. Int J Mol Sci 2022, 23, doi:10.3390/ijms23052401.32. Yadav, P.R.; Munni, M.N.; Campbell, L.; Mostofa, G.; Dobson, L.; Shittu, M.; Pattanayek, S.K.; Uddin, M.J.; Bhusan Das, D. Translation of Polymeric Microneedles for Treatment of Human Diseases: Recent Trends, Progress, and Challenges. Pharmaceutics 2021, 13, doi:10.3390/pharmaceutics13081132.33. Avcil, M.; Çelik, A. Microneedles in Drug Delivery: Progress and Challenges. Micromachines (Basel) 2021, 12, doi:10.3390/mi12111321.34. Priya, B.; Manoj, K.; Navneet, K. A Review of Recent Advancement of Transdermal Drug Delivery Systems. International Journal of Research Development and Technology 2023, 1.35. Sheth, N.S.; Mistry, R.B. Formulation and Evaluation of Transdermal Patches and to Study Permeation Enhancement Effect of Eugenol. J Appl Pharm Sci 2011, 01, 96–101.36. Kim, S.; Kim, J.H.; Jeon, O.; Kwon, I.C.; Park, K. Engineered Polymers for Advanced Drug Delivery. European Journal of Pharmaceutics and Biopharmaceutics 2009, 71, 420–430, doi:10.1016/j.ejpb.2008.09.021.37. Vora, L.K.; Sabri, A.H.; Naser, Y.; Himawan, A.; Hutton, A.R.J.; Anjani, Q.K.; Volpe-Zanutto, F.; Mishra, D.; Li, M.; Rodgers, A.M.; et al. Long-Acting Microneedle Formulations. Adv Drug Deliv Rev 2023, 201, doi:10.1016/j.addr.2023.115055.38. Parhi, R. Recent Advances in Microneedle Designs and Their Applications in Drug and Cosmeceutical Delivery. J Drug Deliv Sci Technol 2022, 75, doi:10.1016/j.jddst.2022.103639.39. Filho, D.; Guerrero, M.; Pariguana, M.; Marican, A.; Durán-Lara, E.F. Hydrogel-Based Microneedle as a Drug Delivery System. Pharmaceutics 2023, 15, doi:10.3390/pharmaceutics15102444.40. Hou, X.; Li, J.; Hong, Y.; Ruan, H.; Long, M.; Feng, N.; Zhang, Y. Advances and Prospects for Hydrogel-Forming Microneedles in Transdermal Drug Delivery. Biomedicines 2023, 11, doi:10.3390/biomedicines11082119.41. Luo, X.; Yang, L.; Cui, Y. Microneedles: Materials, Fabrication, and Biomedical Applications. Biomed Microdevices 2023, 25, doi:10.1007/s10544-023-00658-y.42. Parhi, R.; Divya Supriya, N. Review of Microneedle Based Transdermal Drug Delivery Systems. International Journal of Pharmaceutical Sciences and Nanotechnology 2019, 12, doi:10.37285/ijpsn.2019.12.3.1.43. Halder, J.; Gupta, S.; Kumari, R.; Gupta, G. Das; Rai, V.K. Microneedle Array: Applications, Recent Advances, and Clinical Pertinence in Transdermal Drug Delivery. J Pharm Innov 2021, 16, 558–565, doi:10.1007/s12247-020-09460-2.44. Rathor, S.; Ram, A.; Ghasidas Vishwavidyalaya, G. ADVANCEMENT IN TRANSDERMAL DRUG DELIVERY SYSTEM : MICRONEEDLES. Asian Journal of Pharmaceutical Research and Development 2017, 5, 1–07.45. Oliveira, C.; Teixeira, J.A.; Oliveira, N.; Ferreira, S.; Botelho, C.M. Microneedles’ Device: Design, Fabrication, and Applications. Macromol 2024, 4, 320–355, doi:10.3390/macromol4020019.46. Vora, L.K.; Moffatt, K.; Tekko, I.A.; Paredes, A.J.; Volpe-Zanutto, F.; Mishra, D.; Peng, K.; Raj Singh Thakur, R.; Donnelly, R.F. Microneedle Array Systems for Long-Acting Drug Delivery. European Journal of Pharmaceutics and Biopharmaceutics 2021, 159, 44–76, doi:10.1016/j.ejpb.2020.12.006.47. Singh, P.; Carrier, A.; Chen, Y.; Lin, S.; Wang, J.; Cui, S.; Zhang, X. Polymeric Microneedles for Controlled Transdermal Drug Delivery. Journal of Controlled Release 2019, 315, 97–113, doi:10.1016/j.jconrel.2019.10.022.48. Wang, S.; Zhao, M.; Yan, Y.; Li, P.; Huang, W. Flexible Monitoring, Diagnosis, and Therapy by Microneedles with Versatile Materials and Devices toward Multifunction Scope. Research 2023, 6, 01–28, doi:10.34133/research.0128.49. Loh, J.M.; Lim, Y.J.L.; Tay, J.T.; Cheng, H.M.; Tey, H.L.; Liang, K. Design and Fabrication of Customizable Microneedles Enabled by 3D Printing for Biomedical Applications. Bioact Mater 2024, 32, 222–241, doi:10.1016/j.bioactmat.2023.09.022.50. Serrano Castañeda, P. Desarrollo de Una Nueva Forma Farmacéutica a Base de Microagujas Poliméricas Biodegradables Acopladas a Un Parche Transdérmico Para La Liberación de Fármacos. Tesis, UNIVERSIDAD AUTÓNOMA METROPOLITANA, 2019.51. Magill, E.; Demartis, S.; Gavini, E.; Permana, A.D.; Thakur, R.R.S.; Adrianto, M.F.; Waite, D.; Glover, K.; Picco, C.J.; Korelidou, A.; et al. Solid Implantable Devices for Sustained Drug Delivery. Adv Drug Deliv Rev 2023, 199, doi:10.1016/j.addr.2023.114950.52. Conrad, R. ¿Qué Es Moldeo Por Inyección? Available online: https://www.elastomer.kuraray.com/es/blog/injection-molding/ (accessed on 21 September 2024).53. Xu, J.; Xu, D.; Xuan, X.; He, H. Advances of Microneedles in Biomedical Applications. Molecules 2021, 26, doi:10.3390/molecules26195912.54. Ramadon, D.; McCrudden, M.T.C.; Courtenay, A.J.; Donnelly, R.F. Enhancement Strategies for Transdermal Drug Delivery Systems: Current Trends and Applications. Drug Deliv Transl Res 2022, 12, 758–791, doi:10.1007/s13346-021-00909-6.55. Sabri, A.H.; Kim, Y.; Marlow, M.; Scurr, D.J.; Segal, J.; Banga, A.K.; Kagan, L.; Lee, J.B. Intradermal and Transdermal Drug Delivery Using Microneedles – Fabrication, Performance Evaluation and Application to Lymphatic Delivery. Adv Drug Deliv Rev 2020, 153, 195–215, doi:10.1016/j.addr.2019.10.004.56. Morales Florido, M.I.; Miranda Calderón, J.E.; Gómez Sámano, M.A.; Escobar Chávez, J.J. Microneedles as an Alternative Strategy for Drug Delivery. J Pharm Pharm Sci 2022, 25, 93–109.57. Ebrahiminejad, V.; Rad, Z.F.; Prewett, P.D.; Davies, G.J. Fabrication and Testing of Polymer Microneedles for Transdermal Drug Delivery. Beilstein Journal of Nanotechnologyp0o 2022, 13, 629–640, doi:10.3762/bjnano.13.55.58. Li, W.; Tang, J.; Terry, R.N.; Li, S.; Brunie, A.; Callahan, R.L.; Noel, R.K.; Rodríguez, C.A.; Schwendeman, S.P.; Prausnitz, M.R. Long-Acting Reversible Contraception by Effervescent Microneedle Patch. Sci Adv 2019, 5.59. Li, W.; Chen, J.Y.; Terry, R.N.; Tang, J.; Romanyuk, A.; Schwendeman, S.P.; Prausnitz, M.R. Core-Shell Microneedle Patch for Six-Month Controlled-Release Contraceptive Delivery. Journal of Controlled Release 2022, 347, 489–499, doi:10.1016/j.jconrel.2022.04.051.60. Paredes, A.J.; Ramöller, I.K.; McKenna, P.E.; Abbate, M.T.A.; Volpe-Zanutto, F.; Vora, L.K.; Kilbourne-Brook, M.; Jarrahian, C.; Moffatt, K.; Zhang, C.; et al. Microarray Patches: Breaking down the Barriers to Contraceptive Care and HIV Prevention for Women across the Globe. Adv Drug Deliv Rev 2021, 173, 331–348, doi:10.1016/j.addr.2021.04.002.61. Xu, C.; Wu, Y.; Zhao, L.; Zhou, W.; Li, Y.; Yi, X.; Wang, Y.; Zhang, Q.; Hu, H.; Wang, Z. Transdermal Hormone Delivery: Strategies, Application and Modality Selection. J Drug Deliv Sci Technol 2023, 86, doi:10.1016/j.jddst.2023.104730.62. Yavuz, B.; Chambre, L.; Harrington, K.; Kluge, J.; Valenti, L.; Kaplan, D.L. Silk Fibroin Microneedle Patches for the Sustained Release of Levonorgestrel. ACS Appl Bio Mater 2020, 3, 5375–5382, doi:10.1021/acsabm.0c00671.63. Sivasankaran, S.; Jonnalagadda, S. Advances in Controlled Release Hormonal Technologies for Contraception: A Review of Existing Devices, Underlying Mechanisms, and Future Directions. Journal of Controlled Release 2021, 330, 797–811, doi:10.1016/j.jconrel.2020.12.044.64. VADEMECUM ORTHO EVRA Transdermal Patch 150 Μg/24 H+20 Μg/24 h Available online: https://www.vademecum.es/estados-unidos/medicamento/28003194/ortho-evra-transdermal-patch-150-g-24-h-20-g-24-h (accessed on 18 September 2024).65. Li, W.; Li, S.; Fan, X.; Prausnitz, M.R. Microneedle Patch Designs to Increase Dose Administered to Human Subjects. Journal of Controlled Release 2021, 339, 350–360, doi:10.1016/j.jconrel.2021.09.036.spaORIGINALTrabajo de grado.pdfTrabajo de grado.pdfapplication/pdf1133528https://repositorio.unbosque.edu.co/bitstreams/5994f216-e4bc-428f-bea3-f47c42129827/download2d4dbde23a1b09abc868db9e6319b1d0MD57LICENSElicense.txtlicense.txttext/plain; charset=utf-82000https://repositorio.unbosque.edu.co/bitstreams/3488d174-4a7d-428e-94c3-fe89932ca878/download17cc15b951e7cc6b3728a574117320f9MD54Carta de autorizacion.pdfapplication/pdf746784https://repositorio.unbosque.edu.co/bitstreams/a241cdf4-5e83-47b1-ad2f-e1999bd26600/download50d1fad5d04646c0db64ba23911f52caMD59Anexo 1 Acta de aprobacion.pdfapplication/pdf1612061https://repositorio.unbosque.edu.co/bitstreams/0f8bb21c-3805-4860-9bb5-e35230e2074b/downloadcd98236ce1b2437c9789dccf356155b2MD510CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8899https://repositorio.unbosque.edu.co/bitstreams/f84163eb-1a24-458d-acb8-e425a0d62466/download3b6ce8e9e36c89875e8cf39962fe8920MD58TEXTTrabajo de grado.pdf.txtTrabajo de grado.pdf.txtExtracted texttext/plain83894https://repositorio.unbosque.edu.co/bitstreams/103b6d3e-78df-4632-bbdb-4823d64b2ada/download96fb12b18d34d4d228dda83669147ecaMD511THUMBNAILTrabajo de grado.pdf.jpgTrabajo de grado.pdf.jpgGenerated Thumbnailimage/jpeg5350https://repositorio.unbosque.edu.co/bitstreams/faca2af6-f3df-4d3e-9ec8-3eae7037f962/download781886de6d18912222dccf6df3e0a2d9MD51220.500.12495/14370oai:repositorio.unbosque.edu.co:20.500.12495/143702025-05-17 05:06:11.578http://creativecommons.org/licenses/by-nc-nd/4.0/Attribution-NonCommercial-NoDerivatives 4.0 Internationalopen.accesshttps://repositorio.unbosque.edu.coRepositorio Institucional Universidad El Bosquebibliotecas@biteca.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 |